Topoisomerase IIα content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines
K. Yamazaki, Hiroshi Isobe, Tarou Hanada, Tomoko Betsuyaku, Atsushi Hasegawa, Nobuyuki Hizawa, Shigeaki Ogura, Yoshikazu KawakamiVolume:
39
Language:
english
Pages:
7
DOI:
10.1007/s002800050559
Date:
December, 1996
File:
PDF, 332 KB
english, 1996